After inclusion , subjects with acute symptoms of hemorrhoids , who gave their written , informed consent to participate , were centrally randomized to receive , as outpatients , rSK ( 200000 IU ) or 0.25 % phenylephrine suppositories , which had different organoleptic characteristics .